Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$11.26 -0.67 (-5.62%)
At close: Oct 1, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) Shares Outstanding (Entity) (2020 - 2026)

Updated

Monte Rosa Therapeutics (GLUE) recorded Shares Outstanding (Entity) of 85.23 million in Q2 2026, up 3.7% from 82.19 million a year earlier and up 1.1% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

For FY2025, Monte Rosa Therapeutics reported Shares Outstanding (Entity) of 83.07 million, up 35.1% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for four straight years, with a five-year compound annual growth rate of 118.0% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 61.51 million in FY2024 (+22.7%), 50.14 million in FY2023 (+1.7%), 49.32 million in FY2022 (+97.3%) and 25 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2020.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for 17 consecutive quarters, with growth averaging 28.3% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.5% (Q3 2025) and 820.7% (Q2 2022) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 84.32 million (Q1 2026), 83.07 million (Q4 2025) and 82.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Monte Rosa Therapeutics 1.02 Bn 428.56 Mn - 85.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85.23 Mn
Mar 31, 2026 84.32 Mn
Dec 31, 2025 83.07 Mn
Sep 30, 2025 82.40 Mn
Jun 30, 2025 82.19 Mn
Mar 31, 2025 82.15 Mn
Dec 31, 2024 61.51 Mn
Sep 30, 2024 82.01 Mn
Jun 30, 2024 61.33 Mn
Mar 31, 2024 50.20 Mn
Dec 31, 2023 50.14 Mn
Sep 30, 2023 50.07 Mn
Jun 30, 2023 49.59 Mn
Mar 31, 2023 49.36 Mn
Dec 31, 2022 49.32 Mn
Sep 30, 2022 48.37 Mn
Jun 30, 2022 46.68 Mn
Mar 31, 2022 46.63 Mn
Dec 31, 2021 25.00 Mn
Sep 30, 2021 46.48 Mn
API Access

Monte Rosa Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GLUE&period=max&api_key=YOUR_API_KEY